Quantcast

Latest Parkinson's disease Stories

2014-06-10 20:23:03

Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease NATICK, Mass., June 10, 2014 /PRNewswire/ -- A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease (PD). The CUSTOM-DBS clinical study demonstrated that shorter...

2014-06-10 08:32:25

MIAMI, June 10, 2014 /PRNewswire-USNewswire/ --The National Parkinson Foundation (NPF) released an important study stressing the importance of neurologist care at the 18(th) International Congress of Parkinson's Disease and Movement Disorders in Stockholm this week. The key finding is that expert neurologist care not only saves about 4,600 lives, but better access to this care could prevent the deaths of another nearly 7,000 people with Parkinson's disease (PD) each year in the U.S....

2014-06-10 08:31:23

EMERYVILLE, Calif., June 10, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today presented data on the rater and subject training process utilized in the Phase 2/3 EASED safety and efficacy study of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a condition characterized by involuntary movements without purpose that can become severely disabling, rendering individuals with Parkinson's disease unable to perform routine daily tasks. In order to...

2014-06-09 16:25:26

EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced today that it has initiated a pivotal Phase 3 clinical study of ADS-5102 (amantadine HCl), a high-dose, controlled-release version of amantadine for the treatment of patients with Parkinson's disease who have developed levodopa-induced dyskinesia (LID). LID is a condition characterized by involuntary movements without purpose that can become severely disabling, rendering individuals...

2014-06-03 08:31:43

2014 Marks 10th Anniversary Celebration for Danville Concours/Weekend of Automotive Charity Events - Organization Raises More than $2mm to Support Parkinson's Research and Patient Care Since 2004 DANVILLE, Calif., June 3, 2014 /PRNewswire/ -- When this year's Danville d'Elegance (DDE) Foundation celebrates its upcoming 10th anniversary, September 20-21(st), 2014, with its annual weekend of automotive charity-related events, not only will it be boasting its stature as top fundraiser...

2014-05-29 16:26:44

EMERYVILLE, Calif., May 29, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced a poster presentation at the 18(th) International Congress of Parkinson's Disease and Movement Disorders from June 8 to 12, 2014, in Stockholm, Sweden. The poster (abstract #722) is titled "Rater training and data completeness in the study of ADS-5102 in levodopa-induced dyskinesia (EASED study)." The poster presentation will take place during the poster session "Parkinson's...

2014-05-29 12:29:26

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration...

2014-05-28 23:11:19

Richard London kicks off campaign with Internet Talk Show about "Living with Parkinson's" Monday Nights at 8:00PM Eastern, as well as speaking engagements, martial arts appearances, books, DVDs and CDs. Charlotte, NC (PRWEB) May 28, 2014 When Richard London was first diagnosed with Parkinson’s disease he had already defeated cancer and injuries sustained in a life changing automobile accident. A remarkably positive individual, London began his speaking career with the...

2014-05-27 12:30:25

Nationwide strategic health initiative aims to fill in knowledge gaps and connect patients and caregivers to local resources and one-on-one support NEW YORK, May 27, 2014 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) and AbbVie announced the launch of Partners in Parkinson's, a new strategic health initiative offering comprehensive support to help people with Parkinson's disease (PD) optimize their care at every stage of the disease. "No two cases of Parkinson's disease are...

2014-05-22 08:31:13

--Research Includes Stem Cells, Imaging and Exercise for Cognition-- MIAMI, May 22, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) announced today that it has funded four new grants in Parkinson's disease (PD) research. The four grants target key scientific questions about how Parkinson's develops and how to optimize treatment. "NPF is propelling the most potentially transformative research forward," said Joyce Oberdorf, NPF's President and CEO. "This...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related